Hayat Pharmaceutical Industries Co. PLC's latest marketcap:
As of 07/05/2025, Hayat Pharmaceutical Industries Co. PLC's market capitalization has reached $41.54 M. According to our data, Hayat Pharmaceutical Industries Co. PLC is the 31142th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap | 41.54 M |
Revenue (ttm) | 23.98 M |
Net Income (ttm) | 4.52 M |
Shares Out | 9.5 M |
EPS (ttm) | 0.5 |
Forward PE | 0.00 |
Ex-Dividend Date | 04/10/2025 |
Earnings Date | 07/28/2025 |
Hayat Pharmaceutical Industries Co. PLC's yearly market capitalization.
Date | Market Cap | Change (%) | Global Rank |
---|---|---|---|
07/05/2025 | د.أ41.54 M | 26.53% | 31142 |
12/31/2024 | د.أ23.28 M | 2.08% | 30890 |
12/31/2023 | د.أ22.8 M | -18.64% | 30727 |
12/29/2022 | د.أ28.02 M | -22.16% | 28499 |
12/30/2021 | د.أ36 M | 56.61% | 27438 |
12/31/2020 | د.أ22.99 M | 23.47% | 27110 |
12/31/2019 | د.أ18.62 M | 1.55% | 25207 |
12/31/2018 | د.أ18.34 M | -4.93% | 24333 |
12/31/2017 | د.أ19.28 M | 5.73% | 24371 |
12/29/2016 | د.أ18.24 M | -10.28% | 22290 |
Company Profile
About Hayat Pharmaceutical Industries Co. PLC
Hayat Pharmaceutical Industries Co. PLC is a Jordan-based company specializing in the manufacturing and marketing of generic pharmaceutical products. Established in 1994 and headquartered in Amman, the company serves diverse therapeutic segments with high-quality medications.
Key Offerings
Hayat Pharmaceutical provides a wide range of pharmaceutical products across multiple therapeutic areas, including:
- Allergies
- Cardiovascular system
- Dermatology
- Gastrointestinal system
- Infectious diseases
- Inner ear and balance
- Neurology
- Pain and inflammation management
- Respiratory system
- Vitamins and supplements
- Men’s and women’s health products
Frequently Asked Questions
-
What is Hayat Pharmaceutical Industries Co. PLC's (ASE-HPIC) current market cap?As of 07/05/2025, Hayat Pharmaceutical Industries Co. PLC (including the parent company, if applicable) has an estimated market capitalization of $41.54 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Hayat Pharmaceutical Industries Co. PLC (ASE-HPIC) rank globally by market cap?Hayat Pharmaceutical Industries Co. PLC global market capitalization ranking is approximately 31142 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.